Analyst Consensus ?
ConsensusHold35 ratings
Bullish1645.7%
Neutral1748.6%
Bearish25.7%
1 unmapped firm rating excluded from the percentages.
Stanley Black & Decker, Inc. · SWK · FY2026 Q1 · Calendar Q2 2026
SWK Q1 EPS Beats 35%, Margin Expansion on Track Despite Flat Organic Growth
Stanley Black & Decker's Q1 results show a company mid-transformation: revenue grew 3% year-over-year (flat organically) while adjusted EPS of $0.80 beat consensus of $0.59 by 35%, reflecting operating leverage from cost reductions and a roughly 4-point gross-margin improvement. The completed CAM aerospace fasteners divestiture generated $1.6B in net proceeds applied to debt reduction, supporting a target net debt-to-EBITDA of approximately 2.5x by year-end. Full-year 2026 guidance was maintained at adjusted EPS $4.90-$5.70 with approximately 150 bps of gross-margin expansion. Despite the beat, shares fell 3.1% on the report session before drifting 4.5% higher over the subsequent period.
Reported Before market openNYSEIndustrials
$14.85B market cap
100quality score
Company context
Snapshot as of publicationStanley Black & Decker, Inc. (SWK) is a global enterprise primarily engaged in two core business segments: Tools & Storage and Industrial operations. Its geographical footprint extends across the United States, Canada, the wider Americas region, France, the rest of Europe, and Asia. The Tools & Storage segment provides a comprehensive array of products catering to both professional and consumer markets. For professionals, offerings include high-grade corded and cordless electric power tools, essential equipment, pneumatic tools, and fastening solutions. Consumers can access corded and cordless electric power tools, notably under the BLACK+DECKER brand, alongside lawn and garden equipment, related accessories, various home products, hand tools, power tool accessories, and storage units. This division distributes its merchandise through a diverse network comprising retailers, distributors, and dealers, supplemented by a direct sales force.…
Earnings scorecard
Reported versus consensus
Reported EPS
$0.80
Consensus $1
EPS surprise
+35.4%
Reported versus consensus
Reported revenue
$3.85B
Consensus $3.75B
Revenue surprise
+2.6%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$95.55Previous close
$80Low
$123.61Average
$248High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jun 18, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | May 29, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | May 1, 2026 |
| Baird | Neutral | Neutral | Maintain | Apr 21, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 1, 2026 |
| Citigroup | Buy | Buy | Maintain | Feb 6, 2026 |
| UBS | Buy | Buy | Maintain | Jan 5, 2026 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Jul 8, 2025 |
| Mizuho | Outperform | Neutral | Upgrade | Dec 19, 2024 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 10, 2024 |
| Zelman & Assoc | Buy | Hold | Upgrade | Aug 18, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | Apr 12, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Feb 6, 2023 |
| Longbow Research | Neutral | Buy | Downgrade | Feb 3, 2023 |
| Vertical Research | Hold | Buy | Downgrade | Jul 29, 2022 |
| B of A Securities | Underperform | Underperform | Maintain | Mar 9, 2022 |
| Gabelli & Co. | Buy | Hold | Upgrade | Jun 17, 2021 |
| Nomura Instinet | Buy | Buy | Maintain | May 4, 2020 |
| Nomura | Buy | Buy | Maintain | May 4, 2020 |
| Buckingham Research | Neutral | Neutral | Maintain | Jan 31, 2020 |
| Buckingham | Neutral | Neutral | Maintain | Jan 31, 2020 |
| Bank of America | Buy | Underperform | Upgrade | Nov 14, 2019 |
| Zelman | Hold | Buy | Downgrade | Oct 25, 2019 |
| Keybanc | Overweight | Downgrade | Sep 18, 2019 | |
| Macquarie | Outperform | Outperform | Maintain | Sep 6, 2018 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| MKM Partners | Buy | Buy | Maintain | Jan 25, 2018 |
| FBR Capital | Buy | Buy | Maintain | Oct 25, 2017 |
| Wunderlich Securities | Buy | Buy | Maintain | Oct 27, 2016 |
| Wunderlich | Buy | Buy | Maintain | Oct 27, 2016 |
| Susquehanna | Positive | Positive | Maintain | Apr 14, 2016 |
| Imperial Capital | In Line | In Line | Maintain | Jan 29, 2016 |
| Argus Research | Hold | Buy | Downgrade | May 30, 2013 |
| CLSA | Buy | Buy | Maintain | Feb 26, 2013 |
| Janney Capital | Neutral | Neutral | Maintain | Dec 20, 2012 |
| Raymond James | Market Perform | Outperform | Downgrade | Oct 18, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $95.55. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Goldman Sachs | Joe Ritchie | $93 | $93.05 | -2.7% | Jul 29, 2026 |
| Morgan Stanley | Christopher Snyder | $84 | $79.76 | -12.1% | May 28, 2026 |
| Robert W. Baird | Analyst unavailable | $84 | $75.89 | -12.1% | Apr 30, 2026 |
| Robert W. Baird | Timothy Wojs | $82 | $75.12 | -14.2% | Apr 21, 2026 |
| Morgan Stanley | Analyst unavailable | $87 | $87.29 | -8.9% | Feb 23, 2026 |
| Goldman Sachs | Joe Ritchie | $84 | $85.57 | -12.1% | Feb 5, 2026 |
| Barclays | Analyst unavailable | $100 | $84.63 | +4.7% | Feb 5, 2026 |
| Wells Fargo | Joseph O'Dea | $82 | $82.9 | -14.2% | Jan 14, 2026 |
| UBS | Analyst unavailable | $98 | $77.34 | +2.6% | Jan 5, 2026 |
| Robert W. Baird | Timothy Wojs | $85 | $75.24 | -11.0% | Dec 23, 2025 |
| Morgan Stanley | Analyst unavailable | $88 | $76.02 | -7.9% | Dec 22, 2025 |
| Morgan Stanley | Christopher Snyder | $80 | $65.38 | -16.3% | Oct 14, 2025 |
| Jefferies | Jonathan Matuszewski | $86 | $74.54 | -10.0% | Aug 18, 2025 |
| Goldman Sachs | Analyst unavailable | $80 | $67.77 | -16.3% | Jul 30, 2025 |
| Robert W. Baird | Timothy Wojs | $65 | $58.94 | -32.0% | May 1, 2025 |
| Wells Fargo | Joseph O'Dea | $60 | $58.94 | -37.2% | May 1, 2025 |
| Wells Fargo | Joseph O'Dea | $90 | $81.65 | -5.8% | Jan 7, 2025 |
| Goldman Sachs | Joe Ritchie | $94 | $93.87 | -1.6% | Oct 30, 2024 |
| Morgan Stanley | Jonathan Sakraida | $115 | $96.64 | +20.4% | Sep 10, 2024 |
| Morgan Stanley | Chris Snyder | $107 | $98.36 | +12.0% | Sep 6, 2024 |
| Robert W. Baird | Timothy Wojs | $94 | $106.05 | -1.6% | Jul 31, 2024 |
| Wells Fargo | Joseph O'Dea | $110 | $106.05 | +15.1% | Jul 31, 2024 |
| Robert W. Baird | Timothy Wojs | $80 | $86.95 | -16.3% | Jul 22, 2024 |
| Morgan Stanley | Julian Mitchell | $86 | $86.99 | -10.0% | Jun 4, 2024 |
| Barclays | Julian Mitchell | $107 | $95.46 | +12.0% | Apr 2, 2024 |
| Barclays | Julian Mitchell | $105 | $95.32 | +9.9% | Jan 31, 2024 |
| Morgan Stanley | Dan Oppenheim | $125 | $101.64 | +30.8% | Aug 15, 2022 |
| Wells Fargo | Joseph O'Dea | $105 | $97.33 | +9.9% | Aug 1, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $137 | $114.53 | +43.4% | Jun 6, 2022 |
| Morgan Stanley | Analyst unavailable | $150 | $126.44 | +57.0% | Apr 29, 2022 |
| Citigroup | Analyst unavailable | $110 | $125.83 | +15.1% | Apr 29, 2022 |
| Wells Fargo | Analyst unavailable | $158 | $127.78 | +65.4% | Apr 29, 2022 |
| Robert W. Baird | Timothy Wojs | $188 | $126.9 | +96.8% | Apr 29, 2022 |
| Credit Suisse | Daniel Oppenheim | $165 | $140.92 | +72.7% | Apr 10, 2022 |
| Barclays | Julian Mitchell | $180 | $141.6 | +88.4% | Apr 5, 2022 |
| Bank of America Securities | Ross Gilardi | $140 | $148.4 | +46.5% | Mar 16, 2022 |
| UBS | Markus Mittermaier | $248 | $173.47 | +159.5% | Feb 2, 2022 |
| Deutsche Bank | Nicole Deblase | $223 | $187.17 | +133.4% | Jan 10, 2022 |
| Wolfe Research | Nigel Coe | $246 | $192.86 | +157.5% | Jul 28, 2021 |
Track every rating change on SWK the moment it posts. Free to start.
Start freeMarket reaction
prior-close to event-session close
Stock move
-3.1%
Event window
SPY move
-0.0%
Same window
Abnormal move
-3.1%
Stock minus SPY
Volume
1.3×
Versus trailing sessions
Subsequent drift
+4.5%
Up to 20 sessions
SWKSPY benchmark
Follow SWK with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Q1 revenue rose 3% year-over-year versus a roughly 1% decline in Q4 2025, with adjusted EPS of $0.80 beating the $0.59 consensus estimate by 35%. Gross margin improved approximately 4 points, driven by productivity gains (~40%), fixed-cost restructuring (~40%), and tariff mitigation (~20%). The CAM Aerospace Fasteners divestiture to Howmet Aerospace closed at $1.8B gross proceeds, with $1.6B net applied to debt reduction, up from the $1.5B indicated last quarter. USMCA qualification is now ahead of pace, targeting less than 5% of U.S. sales from China-sourced products by year-end versus a prior target of the same threshold by end-2026. The board authorized up to $500M in share repurchases.
Guidance delta
Maintained. Full-year 2026 guidance was unchanged: adjusted EPS $4.90-$5.70, flat revenue, low-single-digit organic growth, and gross-margin expansion of approximately 150 bps year-over-year. Capex outlook was not mentioned this quarter.
Key takeaways
- Q1 adjusted EPS of $0.80 beat consensus of $0.59 by 35%; revenue of $3.85B beat estimates by 2.6%.
- Gross margin improved approximately 4 points, split roughly 40% productivity, 40% fixed-cost restructuring, and 20% tariff mitigation.
- CAM divestiture completed: $1.8B gross proceeds ($1.6B net) applied to debt reduction; net debt-to-EBITDA target of ~2.5x by year-end.
- 2026 guidance unchanged at adjusted EPS $4.90-$5.70 with ~150 bps gross-margin expansion.
- USMCA qualification ahead of pace, targeting less than 5% of U.S. sales from China-sourced products by year-end.
Management priorities
- Brand activation across DEWALT, CRAFTSMAN, and STANLEY with new product launches including Perform & Protect line.
- Battery-platform innovation: 20V XR, FLEXVOLT, and POWERSHIFT rollout across professional tools.
- Continued tariff mitigation and supply-chain localization under USMCA.
- Share repurchases up to $500M as authorized by the board.
- Operational excellence and productivity improvements targeting 3% net-spend reductions annually.
Related earnings events
IndustrialsALLE · FY2026 Q2 · Calendar Q3 2026Allegion Beats on Q2 Revenue and EPS, Raises Full-Year Outlook as Americas Demand AcceleratesROL · FY2026 Q2 · Calendar Q3 2026Rollins Q2 2026: Revenue Misses as Digital Lead Slowdown Hits OrkinLUV · FY2026 Q2 · Calendar Q3 2026Southwest Airlines Q2 2026: EPS Beats by 84%, Unit Revenue Up 20%, Guidance Cut on Fuel
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-31T09:51:55.504689+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-31T09:51:55.501745+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.